Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaturaka Rodrigo

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAnurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, et al.
Research Square|June 30, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseaseVolker Lohmann, Paul Rothhaar, Christian Heuss, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.
Cell Reports. Medicine|March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionArunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.
Viruses|June 11, 2020
Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019Karla J Helbig, Rowena A Bull, Rebecca Ambrose, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAnurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, et al.
Research Square|June 30, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseaseVolker Lohmann, Paul Rothhaar, Christian Heuss, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.
Cell Reports. Medicine|March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionArunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.
Viruses|June 11, 2020
Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019Karla J Helbig, Rowena A Bull, Rebecca Ambrose, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Pageof 14